Screener
Surgery Partners, Inc. SGRY EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Surgery Partners, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Surgery Partners, Inc.’s 10-Q, filed August 10, 2026. Open the filing →
- Filed
- Aug 10, 2026, 4:14 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001638833-26-000077
FAQ
- What is Surgery Partners, Inc.'s EBITDA margin?
- Surgery Partners, Inc. (SGRY) reported EBITDA margin of 16.7% in Q2 2026.
- How has Surgery Partners, Inc.'s EBITDA margin changed year-over-year?
- Surgery Partners, Inc.'s EBITDA margin increased by 3.3% year-over-year, from 16.1% to 16.7%.
- What is the long-term trend for Surgery Partners, Inc.'s EBITDA margin?
- Over 5 years (2020 to 2025), Surgery Partners, Inc.'s EBITDA margin has grown at a 2.7% compound annual growth rate (CAGR), from 14.9% to 17.1%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.
Ask your AI about Surgery Partners, Inc.'s ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude